Tech solution connects GPs and pharmacists to clinical trials

Monday, 20 May, 2024

Tech solution connects GPs and pharmacists to clinical trials

A new technology solution, called Evripath, hopes to tackle clinical trial recruitment shortfalls and enhance patient care by connecting GPs and pharmacists to clinical trials.

The solution, developed by Evrima Technologies, is a tech-enabled patient referral network built specifically for GPs and pharmacists to learn about current clinical trials in their communities that may be beneficial to their patients.

A recent survey, released in the lead-up to the International Clinical Trial Day (20 May), reveals that only 16% of Australians have engaged in clinical trials.1 Although over 493,000 active clinical trials are taking place globally, 80% of clinical trials are delayed due to recruitment issues.2

The survey identified several barriers to participation, including uncertainty about possible side effects (57%), inconvenience of trial location (44%), and the time commitment required (32%).1 Concerns about being a ‘guinea pig’ for new treatments (25%) and the financial cost of participation (30%) are also notable factors influencing Australia’s decisions.1

Charlotte Bradshaw, Chief Executive Officer at Evrima Technologies, said, “Without clinical trials, medical progress would be significantly hindered, and patients would not have access to innovative and potentially life-saving treatments.

“Last month, Evrima successfully completed a pilot project in New South Wales, along with StrongRoom AI, a medication management platform, and Paratus Clinical, a clinical trial site network, to identify eligible participants via pharmacies and refer them to local clinical trials in their community. This project saw rapid adoption by healthcare professionals and provided a number of patients with the opportunity to participate in clinical trials they wouldn’t normally have been aware of. Evrima plans to expand this network to reach 5 million people by the end of the year.”

Montana Grenfell, B.Pharm, Accredited Pharmacist and Chief of Staff at StrongRoom AI,  said, “As a community pharmacist, I believe that clinical trials play a pivotal role in advancing our arsenal of healthcare solutions, providing hope and possibilities for patients facing challenging health conditions. The success of the Evripath pilot project is a testament to the transformative impact of technology-enabled solutions in clinical trial recruitment.”

Leeanne Lovey, a 63-year-old from Bundoora, Victoria, is an advocate for advancing medical research through her participation in clinical trials. Motivated by her family's history of diabetes, Leeanne embarked on her journey in clinical trials with a focus on diabetes research. Recently, Leeanne participated in a study exploring the efficacy of probiotics as an early intervention for reducing bone loss in post-menopausal women. “I first came across this study on Evrima Technologies’ website, where I immediately enquired and decided that I’d like to participate as I was interested in learning more about bone health at an older age,” Leeanne said.

“The study provided me with invaluable education on making simple dietary changes that can significantly improve my bone health. Additionally, I had access to medical tests that would have been cost-prohibitive otherwise, offering insights into my health that the average person might not have,” Leeanne added.

1. deciBel Research Consumer Survey, which was funded by Evrima Technologies, was conducted amongst 1,000 Australians in March 2024. Data on file.
2. Desai M. Recruitment and retention of participants in clinical studies: Critical issues and challenges. Perspect Clin Res. 2020 Apr-Jun;11(2):51-53. doi: 10.4103/picr.PICR_6_20. Epub 2020 May 6. PMID: 32670827; PMCID: PMC7342339.
3. MTPConnect. (2021). Australia's Clinical Trials Sector Report: Advancing innovative healthcare and powering economic growth.

Image credit: Anthony Eddy

Related News

Patient harms rise by 59% to 18 million globally

Patient harms rose from 11 million to 18 million globally between 1990 and 2019, but the world...

St John Ambulance ACT on hunt for new CEO

After four years in the role, Adrian Watts is set to finish as CEO on 12 July 2024 and move to a...

Urgent call for warning labels on all alcohol products

Despite clear evidence that alcohol causes at least seven types of cancer, a new national survey...

  • All content Copyright © 2024 Westwick-Farrow Pty Ltd